CDEK
← All organizations

Alcon

For profitContributed to NMEWebsite ↗

Also known as: Alaa Mamdouh | ALCON | Alcon, a Novartis Division | Alcon, A Novartis Division | Alcon (China) Ophthalmic Product Co., Ltd. | Alcon Global Medical Affairs, Europe | Alcon Japan Limited | Alcon Japan, Ltd. | ALCON LABS | ALCON LABS INC | ALCON PHARMA | ALCON PHARMS LTD | ALCON RES | Alcon Research | Alcon Research, LLC | Alcon Services AG, Taiwan Branch | Alcon Vision | Matthew Caldwell

Phase 1Phase 2Phase 3Phase 4

Highest phase reached

Phase 4

First clinical trial

Apr 1, 1999

First marketed drug

Jul 8, 1959

First NDA

Jul 8, 1959

Last known activity

Sep 2, 2025

Acquired by Nestle on Jan 1, 1977

Timeline

1940s

  1. Jan 1, 1945

    Alcon— Founded

1970s

  1. Jan 1, 1972

    Owen dermatology company— Acquired

  2. Jan 1, 1977

    Nestle— Acquired By

1980s

  1. Jan 1, 1989

    CooperVision Surgical— Acquired

1990s

  1. Dec 28, 1990

    tropicamide— Marketing Organization

2000s

  1. Aug 19, 2005

    nepafenac— NDA Organization

  2. Sep 13, 2009

    ESBATech AG— Acquired

  3. Dec 14, 2009

    Optonol, Inc.— Acquired

2010s

  1. Jul 6, 2010

    LenSx LasersLenSx Lasers— Acquired

  2. Jul 25, 2012

    Endure Medical, Inc.— Acquired

  3. Apr 19, 2013

    brimonidine— NDA Secondary Org

  4. Aug 28, 2014

    WaveTec Vision— Acquired

  5. Feb 18, 2016

    Transcend Medical— Acquired

2020s

  1. Apr 2, 2025

    Aurion Biotech— Acquired

Drugs by trial phase (97 distinct, 340 trials)

Phase 1 (2 own, 1 via acquisition)

Indications

Approved for

Studied for

Marketed drugs (55)

Subsidiaries (9 direct, 10 total across the full acquisition tree)

Recent trials (50)

Details

Founded
Fort Worth, TX, US Jan 1, 1945
First NDA
Jul 8, 1959
Last known activity
Sep 2, 2025

Designations held

  • Priority review

Notes

Acquired by Novartis